Skip to main content

Advertisement

Table 2 Top ten features (m/z ratio) selected by Wilcoxon rank test method in our 10 fold cross validation.

From: Classification of premalignant pancreatic cancer mass-spectrometry data using decision tree ensembles

Rank Round 1 Round 2 Round 3 Round 4 Round 5 Round 6 Round 7 Round 8 Round 9 Round 10 Most Frequent
1 5798.9 5798.9 4941.6 5801.2 5822.1 5819.8 5801.2 5798.9 4941.6 5801.2 5798.9
2 5801.2 5801.2 5819.8 5798.9 5819.8 5822.1 5798.9 5801.2 11774 5798.9 5801.2
3 4941.6 11472 5822.1 4941.6 5798.9 5798.9 4941.6 11472 5798.9 5796.5 11472
4 5796.5 5819.8 5801.2 5819.8 5801.2 5801.2 5803.5 11477 11770 11472 5819.8
5 5819.8 11477 5798.9 9706.1 11472 11592 5822.1 11774 11477 5803.5 5822.1
6 5822.1 5822.1 4943.6 5822.1 11477 11587 11472 11770 11472 11592 11477
7 4943.6 11468 11592 5803.5 11468 11472 5819.8 11541 5819.8 11541 11541
8 11472 5796.5 11541 5796.5 11770 11541 11477 11537 5822.1 5819.8 4941.6
9 11774 11541 11472 11472 4941.6 11774 5829.1 11468 5801.2 11477 11774
10 11477 11481 11597 9710 11774 5796.5 11541 11481 11481 11468 5796.5
  1. Rank is determined by the probability of the two means between disease and control groups in the training set being significantly different.